Immune Parameters and Morbidity in Hard Drug and Human Immunodeficiency Virus-Exposed but Uninfected Infants

Pediatrics

Volumn 113, Issue 5 I, 2004, Pages 1260-1266

  Neu, Natalie ^a   Leighty, Robert ^b   Adeniyi Jones, Samuel ^c   Diaz, Clemente ^d   Handelsman, Edward ^e   Kaufman, Gary ^f   Paul, Mary E ^g   Rich, Kenneth ^h   Mofenson, Lynne ⁱ   Pitt, Jane ^j  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b C TASC   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f BOSTON MEDICAL CENTER   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

ⁱ EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^j NONE

more..

Author keywords

Drug use; HIV exposed infants; Infant lymphocyte markers

Indexed keywords

COCAINE; ILLICIT DRUG; OPIATE; RNA;

ARTICLE; BIRTH WEIGHT; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INFECTION RISK; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NEWBORN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SELF REPORT; T LYMPHOCYTE; URINALYSIS;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOCYTE SUBSETS; MORBIDITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; SUBSTANCE-RELATED DISORDERS;

EID: 2342633820     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.5.1260     Document Type: Article

References (31)

1. Eisenatein TK, Hillburger ME, Lawrence DMP. Immunomodulation by morphine and other opioids. In: Friedman H, Klein TW, Specter S, eds. Drugs of Abuse, Immunity and Infections. Boca Raton, FL: CRC Press; 1996:103-120
2. Yeager MP, Colacchio TA, Yu CT, et al. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology. 1995;83:500-508
3. Culver K, Ammann A, Partridge J, Wong D, Wara D, Cowan M. Lymphocyte abnormalities in infants born to drug-abusing mothers. J Pediatr. 1987;111:230-235
4. Scheidgger C, Zimmerli W. Infectious complications in drug addicts: seven year review of 269 hospitalized narcotics abusers in Switzerland. Rev Infect Dis. 1989;11:486-493
5. Haverkos HW, Lange WR. Serious infections other than human immunodeficiency virus among intravenous drug users. J Infect Dis. 1990;161: 894-902
6. MacFarlane A, Peng X, Meissler J, et al. Morphine increases susceptibility to oral salmonella typhimurium infection. J Infect Dis. 2000;181: 1350-1358
7. Carballo-Dieguez A, Sahs J, Goetz R, el Sadr W, Sorell S, Gorman J. The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users. Am J Drug Alcohol Abuse. 1994;20:317-329
8. McLachlan C, Crofts N, Wodak A, Crowe S. The effects of methadone on immune function among injecting drug users: a review. Addiction. 1993;88:257-263
9. Carr D, France C. Immune alternations in morphine-treated rhesus monkeys. J Pharmacol Exp Ther. 1993;267:9-15
10. Van Dyke C, Stesin A, Jones R, Chuntharapai A, Seaman W. Cocaine increases natural killer cell activity. J Clin Invest. 1986;77:1387-1390
11. Ruiz, P, Berho M, Steele B, Hao L. Peripheral human lymphocyte maintenance of immune functional capacity and phenotypic characteristics following in vivo cocaine exposure. Clin Immunol Immunopathol. 1998;88:271-276
12. Wybran J, Appelboom T, Famaey JP, Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol. 1979;124:1068-1070
13. Peterson P, Gekker G, Brummitt C, et al. Suppression of human peripheral blood mononuclear cell function by methadone and morphine. J Infect Dis. 1989;159:480-487
14. Thomas P, House R, Bhargava H. Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone. Gen Pharmacol. 1995;26:123-130
15. Roy S, Ramakrishnan S, Loh HH, Lee NM. Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow. Eur J Pharmacol. 1991;195:359-363
16. Bussiere JL, Adler MW, Rogers TJ, Eisenstein TK. Cytokine reversal of morphine-induced suppression of the antibody response. J Pharmacol Exp Ther. 1993;264:59
17. Szabo I, Rojavin M, Bussiere J, Eisenstein TK, Adler MW. Suppression of peritoneal macrophage phagocytosis of candida albicans by opioids. J Pharmcol Exp Ther. 1993;267:703
18. Choi Y, Chuang L, Lam K, et al. Inhibition of chemokine-induced chemotaxis of monkey leukocytes by mu-opioid receptor agonists. In Vivo. 1999;5:389-396
19. Grimm M, Ben-Baruch A, Taub D, Howard O, Wang J, Oppenheim J. Opiate inhibition of chemokine-induced chemotaxis. Ann N Y Acad Sci. 1998;840:9-20
20. Welters I, Menzebach A, Goumon Y, et al. Morphine inhibits NF-κB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology. 2000;6:1677-1684
21. Rodriquez E, Mofenson L, Chang BH, et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS. 1996;10:273-282
22. Hollinger FB, Bremer JW, Myers LE, Gold JWM, McQuay L, HIH/ NIAID/DAIDS/ACTG Virology Laboratories. Standardization of sensitive human immunodeficiency virus co-culture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J Clin Microbiol. 1992;30:1787-1794
23. Mofenson L, Bethel J, Moye J, Flyer P, Nugent R, National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. J Acquir Immune Defic Syndr. 1993;6:1103-1113
24. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22
25. Gesner M, Papaevangelou V, Kim M, et al. Alteration in the proportion of CD4 T lymphocytes in a subgroup of human immunodeficiency virus-exposed-uninfected children. Pediatrics. 1994;4:624-630
26. Clerici M, Saresella M, Colombo F, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood. 2000;12:3866-3871
27. Nielsen SD, Jeppeson D, Kolte L, et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood. 2001;98:398-404
28. Rosen T, Johnson H. Children of methadone-maintained mothers: follow-up to 18 months of age. J Pediatr. 1982;101:192-196
29. Rich K. Immunologic function and AIDS in drug-exposed infants. In: Chasnoff I, ed. Drug Use in Pregnancy: Mother and Child. Boston, MA: MTP Press Limited; 1986:136
30. Roizman B, Whitley RJ, Lopez C. The Human Herpes Viruses. New York, NY: Raven Press; 1993:89
31. Teele D, Klein J, Roser B, the Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: a prospective, cohort study. J Infect Dis. 1989;160:83-94